October 4-7, 2017. In this ESPT2017 symposium progress and applications of pharmacogenomics in oncology, neurodegenerative disease, psychiatry, hemato-oncology, cardio-vascular drugs and diabetes will be addressed.

Also regulatory aspects, the use decision support tools and the application cell free DNA analysis as innovative biomarker to guide lung and/or prostate cancer therapy will be highlighted.

During the meeting, there will be discussion groups, workshops and poster presentations as well as the ESPT General Assembly.